Insider trade

Officer sold ~$19K of UTHR shares in the open market

Traded Jan 15, 2026 · Filed Jan 16, 2026

Why it stands out

United Therapeutics's & GENERAL COUNSEL sold $19K of United Therapeutics shares. The filing says it was made under a pre-arranged trading plan.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Officer<$25KPre-arranged plan referenced

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$18,990

Shares × reported transaction price

Timing vs results

78 days after results of Oct 29, 2025, 41 days before results of Feb 25, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025.

Filed 8mo ago

Traded Feb 9 · filed 2 days later

Derivative exercise or conversion — not an open-market buy.

Scheduled in advanceFiled 8mo ago

Filed 8mo ago

Traded Feb 9 · filed 2 days later

Derivative exercise or conversion — not an open-market buy.